| Net income (loss) | |
| Depreciation and amortization | |
| Provision for bad debts | 33.88M |
| Equity in earnings of joint ventures | -8.13M |
| Distributions from joint ventures | 2.93M |
| Deferred rent amortization | |
| Amortization of deferred financing cost | 4.24M |
| Amortization of bond discount | |
| Loss (gain) on sale and disposal of equipment | 0 |
| Loss on extinguishment of debt | |
| Amortization of cash flow hedge | |
| Stock-based compensation | 4.92M |
| Accounts receivable | -53.28M |
| Other current assets | 751K |
| Other assets | |
| Deferred revenue | 60K |
| Accounts payable and accrued expenses | 9.04M |
| Net cash provided by operating activities | |
| Purchase of imaging facilities | -6.6M |
| Purchase of property and equipment | -52.11M |
| Proceeds from insurance claims on damaged equipment | |
| Proceeds from sale of equipment | 63K |
| Purchase of equity interest in joint ventures | |
| Net cash used in investing activities | |
| Principal payments on notes and leases payable | -9.22M |
| Repayment of debt | |
| Proceeds from borrowings | |
| Deferred financing costs | -945K |
| Proceeds from, net of payments on, line of credit | |
| Payments to counterparties of interest rate swaps, net of amounts received | |
| Distributions to noncontrolling interests | -492K |
| Proceeds from issuance of common stock upon exercise of options/warrants | |
| Net cash provided by financing activities | |
| EFFECT OF EXCHANGE RATE CHANGES ON CASH | -13K |
| NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS | -88K |
| CASH AND CASH EQUIVALENTS, beginning of period | 446K |
| CASH AND CASH EQUIVALENTS, end of period | 358K |
| Cash paid during the period for interest | |